Page not found

Perhaps you were looking for one of these?

Latest

• CSF sphingomyelin metabolites in Alzheimer's disease, neurodegeneration, and neuroinflammation
• Large-scale proteome analysis of CSF implicates altered glucose metabolism in Alzheimer's disease
• Liver-specific polygenic risk score is more strongly associated than genome-wide score with Alzheimer's disease diagnosis in a case-control analysis
• Impact of a Rheumatology Clinic Protocol on Tobacco Cessation Quit Line Referrals
• Pilot proteomic analysis of cerebrospinal fluid in Alzheimer's disease
• Cerebrospinal fluid metabolomics identifies 19 brain-related phenotype associations
• EDI statement
• Teaching statement
• Connecting Rheumatology Patients to Primary Care for High Blood Pressure: Specialty clinic protocol improves follow-up and population blood pressures
• RNA expression profiling in sulfamethoxazole-treated patients with a range of in vitro lymphocyte cytotoxicity phenotypes